Purchase Order 75N95C19P00070

<p>The National Center for Advancing Translational Sciences (NCATS) awarded a purchase order to Promega Corporation on September 19, 2019, with a ceiling value of $24,670.75 for firm fixed price commercial items. Place of performance is Madison, Wisconsin. The solicitation was posted August 29, 2019, with a due date of September 13, 2019, and ultimate completion is September 30, 2019. No small business set-aside was used.</p>

This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...

<p>The NIH Clinical Center awarded a purchase order to Promega Corporation for $35,394.30 on June 22, 2020, for renewal of equipment. Work is performed at Promega's location in Madison, Wisconsin. The order carries firm fixed price terms and is scheduled for completion by August 21, 2020. The underlying solicitation was posted as a pre-solicitation opportunity on May 28, 2020, with a due date of June 8, 2020.</p>

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,294.20 firm fixed price purchase order to Promega Corporation for CASPASE-GLO(R) 3/7 ASSAY, 100ML. The contract has a completion date of September 8, 2023 and was awarded on August 18, 2023. This order is not associated with a set-aside program. Promega Corporation is a global life sciences company that provides various biological research and diagnostic...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...

This is a $83,800 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation. The award is to procure custom Promega assays and reagents, including the MTase-Glo Methyltransferase Assay, to support NCATS's Antiviral Program for Pandemics. The award is non-competitive as Promega's reagents are specifically engineered and optimized for NCATS's high-throughput screening and...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The $86,800.00 contract is for Promega Corporation, a global life sciences company, to provide reagent kits and assays. The award is not set aside for any small business designations. Promega holds several significant federal contract vehicles, including Blanket Purchase Agreements with the Defense Health...

This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Promega Corporation for a methyltransferase assay kit, consisting of 2,000 assays. The $45,504.00 contract is to support NCATS' mission of catalyzing innovative methods and technologies for developing diagnostics and therapeutics. The assay kits will be used in NCATS' methyltransferase project to identify...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $38,508 firm fixed price purchase order to Promega Corporation of Madison, Wisconsin. The order is for luminescence detection reagents including Promega product numbers G8092, G8093, G9713, and N1150 to support ongoing high-throughput screening of internal libraries for viruses such as Rift Valley Fever Virus and SARS-CoV-2. The reagents will be used to...